Biotech stocks normally move up only when there is some positive news, otherwise they just stagante in a very narrow trading margin .. However ANLY has moved up almost every single day after hitting 49, on pretty low volume .. I am trying to compile daily volumes and price changes (intraday as well as based on closing prices) to send to SEC to let them have a look if the price movement looks like a well coordinated collusion move by certain people
This is not a trading stock. This one you buy and hold - either what they are working on works or it doesn't - if it works you get rich - if not...well you know how that ends...
Of course it is going to be revolutionary .. But not yet .. I am talking of price movement in last 2 weeks, which is going up on very volume and no news
Yet Again .. Very Low Volume and Price Goes Up and Up .. Clearly some investors are pumping up the prices in collusion .. Disgusting .. Why cannot SEC take notice
Dude - Do you have a clue what you are talking about? This Company is changing medicine. Do some research you freak.
Without any specific news, no real product or profit, the stock has moved everyday after hitting 49 .. I can only suspect manipulation by a small group of investors
I know teddy is a moron ................ he still has a $75 PT on this POS and we all know ISIS is cheap at $31 and has a broader technology platform via Antisense drug discovery. The world of dsRNAi is going to tremble when ISIS places a ssRNAi drug in P1 trial .......... $7
may be having an effect on some RNAi stocks today, as it appears to be a possible game changer in gene therapy.........good luck All
Has a buy on Alny and a sell on ISIS due to valuation. Isis has 33 drug pipeline. and 10 drugs in Phase 2 and 3.
Isis TTR drug is 18 months ahead of Alny's. ISIS drugs have been tested on 5,000 + people. Ted T said buy ALNY when it was 65, he has struck out again.
It has been PR'd and given the passage of time, I am hoping to find out more information on which of the ALNY 5x15 candidates was selected for using the DPC system. I am particularly interested in finding out what the candidate is targeting. Request more clear?
rnai_inv............ My question comes from: "Cambridge, Mass. and Pasadena, Calif., January 5, 2012 – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, and Arrowhead Research Corporation, (Nasdaq: ARWR) a nanomedicine company with development programs in RNAi and obesity, announced today that they have entered into a collaboration and joint licensing agreement.
Alnylam has granted Arrowhead a license under its intellectual property that enables the discovery, development, and commercialization of an RNAi therapeutic targeting the hepatitis B virus (HBV). Alnylam is eligible to receive from Arrowhead milestone payments and royalties on sales of product resulting from the license. In addition, Alnylam has received a license from Arrowhead to utilize their Dynamic Polyconjugate (DPC) delivery technology for an RNAi therapeutic product. Alnylam expects to deploy this technology for an undisclosed target in its "Alnylam 5x15" pipeline which is focused on genetically defined targets and diseases. Arrowhead is eligible to receive from Alnylam milestone payments and royalties on sales of product resulting from the license. No additional financial details were disclosed.
"We view Arrowhead's DPC technology as a promising emerging delivery approach, with the potential to complement our existing delivery platform which currently includes lipid nanoparticles and our siRNA conjugate platform," said Laurence Reid, Ph.D., Senior Vice President and Chief Business Officer of Alnylam. "In addition, by granting Arrowhead a license for their HBV program, we are enabling their efforts with access to Alnylam intellectual property which we believe is critical for the development and commercialization of RNAi therapeutics. We look forward to continuing to work with Arrowhead, who is already a partner and licensee of Alnylam."
I'm not sure what you are asking? Alny has not disclosed anything. And even if they would be trying and testing DPCs they sure are not going to pr it. If you know a little about the history of how they tried to get around TKMR..
Alny has their own delivery technology which they are trying to sell and disclosing they are using/testing DPCs wouldn't really help ...